Report Detail
Global Drug Metabolism and Pharmacokinetics (DMPK) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4591400 |
- 21 May, 2024 |
- Global |
- 123 Pages |
- GIR (Global Info Research) |
- Other
DMPK is an acronym that stands for drug metabolism and pharmacokinetics. This is a discipline that helps to identify drugs that are likely to be suitable for advancement through the drug development process. It considers how the drug is metabolized and processed by the body.
According to our (Global Info Research) latest study, the global Drug Metabolism and Pharmacokinetics (DMPK) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Drug Metabolism and Pharmacokinetics (DMPK) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Drug Metabolism and Pharmacokinetics (DMPK) market size and forecasts, in consumption value ($ Million), 2019-2030
Global Drug Metabolism and Pharmacokinetics (DMPK) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Drug Metabolism and Pharmacokinetics (DMPK) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Drug Metabolism and Pharmacokinetics (DMPK) market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Metabolism and Pharmacokinetics (DMPK)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Metabolism and Pharmacokinetics (DMPK) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins Discovery, Inotiv, Evotec, Sai Life Sciences, Sygnature Discovery, WuXi AppTec, Hangzhou Tigermed Consulting Co, Q2 Solutions, Jubilant Biosys, Frontage Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug Metabolism and Pharmacokinetics (DMPK) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Drug Metabolism and Pharmacokinetics (DMPK) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Small Molecules
Biologics
Market segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
Market segment by players, this report covers
Eurofins Discovery
Inotiv
Evotec
Sai Life Sciences
Sygnature Discovery
WuXi AppTec
Hangzhou Tigermed Consulting Co
Q2 Solutions
Jubilant Biosys
Frontage Laboratories
Invitrocue
Creative Biolabs
CrownBioscience
Agilent
H3D
LABCORP
Bioduro-Sundia
Allucent
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Metabolism and Pharmacokinetics (DMPK) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Metabolism and Pharmacokinetics (DMPK), with revenue, gross margin, and global market share of Drug Metabolism and Pharmacokinetics (DMPK) from 2019 to 2024.
Chapter 3, the Drug Metabolism and Pharmacokinetics (DMPK) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Metabolism and Pharmacokinetics (DMPK) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Metabolism and Pharmacokinetics (DMPK).
Chapter 13, to describe Drug Metabolism and Pharmacokinetics (DMPK) research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Drug Metabolism and Pharmacokinetics (DMPK) by Type
- 1.3.1 Overview: Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value Market Share by Type in 2023
- 1.3.3 Small Molecules
- 1.3.4 Biologics
- 1.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Market by Application
- 1.4.1 Overview: Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Biopharmaceutical Companies
- 1.4.3 Government and Academic Institutes
- 1.4.4 Others
- 1.5 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size & Forecast
- 1.6 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast by Region
- 1.6.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region, (2019-2030)
- 1.6.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospect (2019-2030)
- 1.6.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospect (2019-2030)
- 1.6.6 South America Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Eurofins Discovery
- 2.1.1 Eurofins Discovery Details
- 2.1.2 Eurofins Discovery Major Business
- 2.1.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.1.4 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Eurofins Discovery Recent Developments and Future Plans
- 2.2 Inotiv
- 2.2.1 Inotiv Details
- 2.2.2 Inotiv Major Business
- 2.2.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.2.4 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Inotiv Recent Developments and Future Plans
- 2.3 Evotec
- 2.3.1 Evotec Details
- 2.3.2 Evotec Major Business
- 2.3.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.3.4 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Evotec Recent Developments and Future Plans
- 2.4 Sai Life Sciences
- 2.4.1 Sai Life Sciences Details
- 2.4.2 Sai Life Sciences Major Business
- 2.4.3 Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.4.4 Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Sai Life Sciences Recent Developments and Future Plans
- 2.5 Sygnature Discovery
- 2.5.1 Sygnature Discovery Details
- 2.5.2 Sygnature Discovery Major Business
- 2.5.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.5.4 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Sygnature Discovery Recent Developments and Future Plans
- 2.6 WuXi AppTec
- 2.6.1 WuXi AppTec Details
- 2.6.2 WuXi AppTec Major Business
- 2.6.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.6.4 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 WuXi AppTec Recent Developments and Future Plans
- 2.7 Hangzhou Tigermed Consulting Co
- 2.7.1 Hangzhou Tigermed Consulting Co Details
- 2.7.2 Hangzhou Tigermed Consulting Co Major Business
- 2.7.3 Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.7.4 Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Hangzhou Tigermed Consulting Co Recent Developments and Future Plans
- 2.8 Q2 Solutions
- 2.8.1 Q2 Solutions Details
- 2.8.2 Q2 Solutions Major Business
- 2.8.3 Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.8.4 Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Q2 Solutions Recent Developments and Future Plans
- 2.9 Jubilant Biosys
- 2.9.1 Jubilant Biosys Details
- 2.9.2 Jubilant Biosys Major Business
- 2.9.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.9.4 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Jubilant Biosys Recent Developments and Future Plans
- 2.10 Frontage Laboratories
- 2.10.1 Frontage Laboratories Details
- 2.10.2 Frontage Laboratories Major Business
- 2.10.3 Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.10.4 Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 Frontage Laboratories Recent Developments and Future Plans
- 2.11 Invitrocue
- 2.11.1 Invitrocue Details
- 2.11.2 Invitrocue Major Business
- 2.11.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.11.4 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.11.5 Invitrocue Recent Developments and Future Plans
- 2.12 Creative Biolabs
- 2.12.1 Creative Biolabs Details
- 2.12.2 Creative Biolabs Major Business
- 2.12.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.12.4 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.12.5 Creative Biolabs Recent Developments and Future Plans
- 2.13 CrownBioscience
- 2.13.1 CrownBioscience Details
- 2.13.2 CrownBioscience Major Business
- 2.13.3 CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.13.4 CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.13.5 CrownBioscience Recent Developments and Future Plans
- 2.14 Agilent
- 2.14.1 Agilent Details
- 2.14.2 Agilent Major Business
- 2.14.3 Agilent Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.14.4 Agilent Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.14.5 Agilent Recent Developments and Future Plans
- 2.15 H3D
- 2.15.1 H3D Details
- 2.15.2 H3D Major Business
- 2.15.3 H3D Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.15.4 H3D Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.15.5 H3D Recent Developments and Future Plans
- 2.16 LABCORP
- 2.16.1 LABCORP Details
- 2.16.2 LABCORP Major Business
- 2.16.3 LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.16.4 LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.16.5 LABCORP Recent Developments and Future Plans
- 2.17 Bioduro-Sundia
- 2.17.1 Bioduro-Sundia Details
- 2.17.2 Bioduro-Sundia Major Business
- 2.17.3 Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.17.4 Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.17.5 Bioduro-Sundia Recent Developments and Future Plans
- 2.18 Allucent
- 2.18.1 Allucent Details
- 2.18.2 Allucent Major Business
- 2.18.3 Allucent Drug Metabolism and Pharmacokinetics (DMPK) Product and Solutions
- 2.18.4 Allucent Drug Metabolism and Pharmacokinetics (DMPK) Revenue, Gross Margin and Market Share (2019-2024)
- 2.18.5 Allucent Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Drug Metabolism and Pharmacokinetics (DMPK) by Company Revenue
- 3.2.2 Top 3 Drug Metabolism and Pharmacokinetics (DMPK) Players Market Share in 2023
- 3.2.3 Top 6 Drug Metabolism and Pharmacokinetics (DMPK) Players Market Share in 2023
- 3.3 Drug Metabolism and Pharmacokinetics (DMPK) Market: Overall Company Footprint Analysis
- 3.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Market: Region Footprint
- 3.3.2 Drug Metabolism and Pharmacokinetics (DMPK) Market: Company Product Type Footprint
- 3.3.3 Drug Metabolism and Pharmacokinetics (DMPK) Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Type (2019-2030)
- 6.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2030)
- 6.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country
- 6.3.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Country (2019-2030)
- 6.3.2 United States Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 6.3.3 Canada Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Type (2019-2030)
- 7.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Application (2019-2030)
- 7.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country
- 7.3.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Country (2019-2030)
- 7.3.2 Germany Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 7.3.3 France Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 7.3.5 Russia Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 7.3.6 Italy Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region
- 8.3.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Region (2019-2030)
- 8.3.2 China Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 8.3.3 Japan Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 8.3.5 India Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 8.3.7 Australia Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Type (2019-2030)
- 9.2 South America Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Application (2019-2030)
- 9.3 South America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country
- 9.3.1 South America Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country
- 10.3.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
- 10.3.4 UAE Drug Metabolism and Pharmacokinetics (DMPK) Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Drug Metabolism and Pharmacokinetics (DMPK) Market Drivers
- 11.2 Drug Metabolism and Pharmacokinetics (DMPK) Market Restraints
- 11.3 Drug Metabolism and Pharmacokinetics (DMPK) Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Drug Metabolism and Pharmacokinetics (DMPK) Industry Chain
- 12.2 Drug Metabolism and Pharmacokinetics (DMPK) Upstream Analysis
- 12.3 Drug Metabolism and Pharmacokinetics (DMPK) Midstream Analysis
- 12.4 Drug Metabolism and Pharmacokinetics (DMPK) Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Drug Metabolism and Pharmacokinetics (DMPK). Industry analysis & Market Report on Drug Metabolism and Pharmacokinetics (DMPK) is a syndicated market report, published as Global Drug Metabolism and Pharmacokinetics (DMPK) Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Drug Metabolism and Pharmacokinetics (DMPK) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
